Influence of IL-6, COL1A1, and VDR gene polymorphisms on bone mineral density in Crohn's disease

被引:25
作者
Todhunter, CE
Sutherland-Craggs, A
Bartram, SA
Donaldson, PT
Daly, AK
Francis, RM
Mansfield, JC
Thompson, NP
机构
[1] Univ Newcastle Upon Tyne, Newcastle upon Tyne Hosp NHS Trust, Dept Med, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England
[2] Univ Newcastle Upon Tyne, Sch Clin Med Sci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England
[3] Univ Newcastle Upon Tyne, Sch Clin & Lab Sci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England
[4] Univ Newcastle Upon Tyne, Newcastle upon Tyne Hosp NHS Trust, Musculoskeletal Unit, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England
[5] Univ Newcastle Upon Tyne, Newcastle upon Tyne Hosp NHS Trust, Dept Med, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England
关键词
D O I
10.1136/gut.2005.064212
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background: Osteoporosis is an important cause of morbidity in patients with Crohn's disease. The pathogenesis of reduced bone mineral density (BMD) is multifactorial. A range of genetic factors have been implicated in other populations of patients with osteoporosis. Aim: To investigate the influence of interleukin 6 (IL-6), collagen type 1 alpha 1 (COL1A1), and vitamin D receptor gene (VDR) single nucleotide polymorphisms (SNP) on BMD in patients with Crohn's disease. Patients: A cohort of 245 well characterised patients with Crohn's disease were recruited from the inflammatory bowel disease register at the Freeman Hospital and Royal Victoria Infirmary, Newcastle upon Tyne, and the Queen Elizabeth Hospital, Gateshead, UK. Methods: Patients were genotyped for IL-6 C-174G SNP, COL1A1 Sp1 binding site G T SNP, VDR Taq1, and Fok1 SNPs, and CARD15 R702W, G908R, and L1007fs SNPs. BMD was measured at the lumbar spine (LSP) and hip using dual energy x ray absorptiometry. Results: A total of 158 female and 87 male patients, aged 24-70 years (mean 44), were recruited. There were no significant differences in the distribution of the tested SNPs when analysed for age, body mass index, pre/post-menopausal status, smoking, or steroid use. Two hundred and thirteen patients were genotyped for the IL-6 SNP. LSP and total hip BMD was significantly lower in patients with the GG genotype (48%) than the CC genotype (15%) (p = 0.041, p = 0.014). One hundred and eighty patients were genotyped for the COL1A1 SNP. There was no significant difference in BMD at LSP. Hip BMD was significantly lower in heterozygous patients compared with homozygous wild-types (p = 0.034). There were no significant differences in BMD between genotypes for the two VDR SNPs or the CARD15 genotypes examined. Conclusion: IL-6 and COL1A1 gene polymorphisms influence BMD in patients with Crohn's disease but the particular VDR gene polymorphisms studied do not have a major effect.
引用
收藏
页码:1579 / 1584
页数:6
相关论文
共 46 条
[1]  
ADADCHI JD, 1997, NEW ENGL J MED, V337, P382
[2]   Gender, age, and body weight are the major predictive factors for bone mineral density in Crohn's disease: A case-control cross-sectional study of 113 patients [J].
Andreassen, H ;
Hylander, E ;
Rix, M .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 1999, 94 (03) :824-828
[3]   A randomized controlled trial of calcium with vitamin D, alone or in combination with intravenous pamidronate, for the treatment of low bone mineral density associated with Crohn's disease [J].
Bartram, SA ;
Peaston, RT ;
Rawlings, DJ ;
Francis, RM ;
Thompson, NP .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2003, 18 (11-12) :1121-1127
[4]   The incidence of fracture among patients with inflammatory dowel disease - A population-based cohort study [J].
Bernstein, CN ;
Blanchard, JF ;
Leslie, W ;
Wajda, A ;
Yu, BN .
ANNALS OF INTERNAL MEDICINE, 2000, 133 (10) :795-799
[5]   Hip fractures in patients with inflammatory bowel disease and their relationship to corticosteroid use: a population based cohort study [J].
Card, T ;
West, J ;
Hubbard, R ;
Logan, RFA .
GUT, 2004, 53 (02) :251-255
[6]  
Cooper GS, 1996, J BONE MINER RES, V11, P1841
[7]   The contribution of NOD2 gene mutations to the risk and site of disease in inflammatory bowel disease [J].
Cuthbert, AP ;
Fisher, SA ;
Mirza, MM ;
King, K ;
Hampe, J ;
Croucher, PJP ;
Mascheretti, S ;
Sanderson, J ;
Forbes, A ;
Mansfield, J ;
Schreiber, S ;
Lewis, CM ;
Mathew, CG .
GASTROENTEROLOGY, 2002, 122 (04) :867-874
[8]   CALCIUM-ABSORPTION ON HIGH AND LOW-CALCIUM INTAKES IN RELATION TO VITAMIN-D-RECEPTOR GENOTYPE [J].
DAWSONHUGHES, B ;
HARRIS, SS ;
FINNERAN, S .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1995, 80 (12) :3657-3661
[9]   A UK Consensus Group on management of glucocorticoid-induced osteoporosis: an update [J].
Eastell, R ;
Reid, DM ;
Compston, J ;
Cooper, C ;
Fogelman, I ;
Francis, RM ;
Hosking, DJ ;
Purdie, DW ;
Ralston, SH ;
Reeve, J ;
Russell, RGG ;
Stevenson, JC ;
Torgerson, DJ .
JOURNAL OF INTERNAL MEDICINE, 1998, 244 (04) :271-292
[10]  
Ferrari SL, 2001, ARTHRITIS RHEUM-US, V44, P196, DOI 10.1002/1529-0131(200101)44:1<196::AID-ANR26>3.0.CO